Burning Rock Biotech (BNR) Gross Profit: 2020-2025
Historic Gross Profit for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to $14.1 million.
- Burning Rock Biotech's Gross Profit rose 0.65% to $14.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.5 million, marking a year-over-year increase of 4.94%. This contributed to the annual value of $49.6 million for FY2024, which is 2.96% down from last year.
- As of Q3 2025, Burning Rock Biotech's Gross Profit stood at $14.1 million, which was down 7.86% from $15.3 million recorded in Q2 2025.
- In the past 5 years, Burning Rock Biotech's Gross Profit ranged from a high of $17.0 million in Q4 2021 and a low of $10.7 million during Q4 2024.
- Over the past 3 years, Burning Rock Biotech's median Gross Profit value was $13.1 million (recorded in 2023), while the average stood at $13.1 million.
- In the last 5 years, Burning Rock Biotech's Gross Profit decreased by 24.07% in 2023 and then increased by 20.37% in 2024.
- Burning Rock Biotech's Gross Profit (MRQ) stood at $17.0 million in 2021, then dropped by 6.30% to $15.9 million in 2022, then decreased by 24.07% to $12.1 million in 2023, then fell by 11.03% to $10.7 million in 2024, then soared by 30.84% to $14.1 million in 2025.
- Its last three reported values are $14.1 million in Q3 2025, $15.3 million for Q2 2025, and $13.4 million during Q1 2025.